Enjamb Labs
YC X26San Francisco, US · Founded 2025 · 2 employees · 1 known investors
Enjamb develops an agentic AI platform for biopharma R&D teams that automates drug discovery, trial execution, and regulatory filings. The platform integrates with existing systems to support programs from early discovery through FDA approval.
AI & Machine LearningBiotechDeep TechEnterprise SoftwareSaaSArtificial IntelligenceB2BAutomationin /enjamb/@enjamblabsycombinator.com ↗
Founders & leadership· Y Combinator alumni (X26)
RM
Rayan Mubarakin𝕏Founder
MD
Maadhav Deekshithain𝕏Founder
Investors · 1
In the news
- Enjamb - Where drug teams run their entire programycombinator.com · 2026